|
|
| SN |
Author |
Title |
Status |
| 2001 |
Swati |
AN ELUCIDATION USING AYURVEDA MEDICATION FOR NEURO DEVELOPMENTAL DISORDERS IN CHILDREN |
Accepted |
| 2002 |
Swati |
AN ELUCIDATION USING AYURVEDA MEDICATION FOR NEURO DEVELOPMENTAL DISORDERS IN CHILDREN |
Under Review |
| 2003 |
Swati |
AN ELUCIDATION USING AYURVEDA MEDICATION FOR NEURO DEVELOPMENTAL DISORDERS IN CHILDREN |
Under Review |
| 2004 |
H NALINI |
SIDDHA HERBO-MINERAL FORMULATION OF VAAYU MATHIRAI – A REVIEW |
Accepted |
| 2005 |
Tushar Kanti |
ESTABLISHMENT OF CONTAMINATION FREE MATERIAL TRANSFER PROCESS THOUGH PASS BOX ADJACENT TO CLEAN ROOM OF PHARMACEUTICAL INDUSTRY |
Accepted |
| 2006 |
Sharma S. |
MANAGEMENT OF MANDIBULAR FRACTURES- A CASE REPORT AND OVERVIEW OF FIXATION TECHNIQUES AND PRINCIPLES |
Accepted |
| 2007 |
Shobhit Pratap Singh |
SMILE DESIGN |
Accepted |
| 2008 |
Pradeep |
PREPARATION AND PHARMACEUTICAL CLINICAL STUDY OF SWITRARI TAILA IN SWITRA/SWET KUSTHA |
Accepted |
| 2009 |
Vikas I. Bodhak |
PHYTOCHEMICAL AND PHARMACOLOGICAL REVIEW ON BACOPA MONNERI |
Under Review |
| 2010 |
Devi |
FORMULATION AND EVALUATIONOF VALSARTANMICROSPONGESFORTHE TREATMENTOFCONGESTIVEHEART FAILURE |
Accepted |
| 2011 |
Shahina K.A. |
ANTIBACTERIAL ACTIVITY OF BARK OF SCLEROPYRUM PENTANDRUM [DENNST.] MABB |
Accepted |
| 2012 |
Vikrant |
DEVELOPMENT, VALIDATION AND CHARACTERIZATION OF DEGRADANTS BY STABILITY INDICATING HPLC METHOD FOR ESTIMATION OF ELIGLUSTAT |
Accepted |
| 2013 |
SANKARI |
NUTRITION DURING COVID-19 |
Accepted |
| 2014 |
Anuja A. Kulkarni |
YONI DHUPANA CHIKITSA – A LITERARY REVIEW |
Accepted |
| 2015 |
Daisy Chella Kumari |
FORMULATION AND EVALUATION OF MOXIFLOXACIN HYDROCHLORIDE
OCULAR INSERTS
|
Accepted |
| 2016 |
Jahanvi R. Parikh |
A REVIEW ON MICROEMULSION-BASED HYDROGEL FORMULATIONS: A RECENT APPROCH FOR TOPICAL DELIVERY OF FLUCONAZOLE |
Under Review |
| 2017 |
Rosy |
IDEOLOGY OF FASTING (UPWAS) IN AYURVEDA AND NATUROPATHY
|
Accepted |
| 2018 |
Anita Makwana |
THERMOSENSITIVE IN SITU GEL: A NOVEL APPROACH FOR GLAUCOMA THERAPY |
Under Review |
| 2019 |
Sonia |
NANO PARTICLES |
Under Review |
| 2020 |
Ravindra |
CASE REPORT ON AYURVEDA MANAGEMENT OF POLYCYSTIC OVARIAN SYNDROME (PCOS) |
Accepted |
| 2021 |
Sonia |
CURRENT AND FUTURE PROSPECTS ON NANO DRUG DELIVERY SYSTEM |
Under Review |
| 2022 |
Kalyani Gudadhe |
DEVELOPMENT AND VALIDATION OF RP-HPLC FOR THE SIMULTANEOUS ESTIMATION OF METFORMIN AND ALOGLIPTIN IN BULK AND COMBINED TABLET DOSAGE FORM |
Accepted |
| 2023 |
Sruthy |
A Review on Nanocochleate as Drug Delivery Vehicle |
Accepted |
| 2024 |
Remya |
COVID-19 - DRUG REPURPOSING |
Accepted |
| 2025 |
Ayushi Patel |
A REVIEW: TRADITIONAL MEDICINAL HERBS USED TO PREPARE AN ANTI-FUNGAL GEL. |
Accepted |
| 2026 |
Keerthana K.V. |
REMEDISIVIR AND ITS ANTIVIRAL ACTIVITY AGAINST COVID 19 |
Under Review |
| 2027 |
John Flamitha.J. |
A COMPREHENSIVE REVIEW ON EFFICACY OF MEDICINES USED IN THE TREATMENT OF SARS COV2- A COMPARATIVE STUDY |
Under Review |
| 2028 |
Sakthivigneswari |
SCREENING OF PRELIMINARY PHYTOCHEMICAL ANALYSIS AND ANTIBACTERIAL ACTIVITIES OF LEUCAS ASPERA (WILD.) LINK |
Accepted |
| 2029 |
A.Jasmine |
CARDIOVASCULAR COMPLICATIONS OF COVID-19 |
Under Review |
| 2030 |
Sagar S. Sangale |
ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF PHYTOSTEROL FROM ABUTILON INDICUM (L.) SWEET BY HPLC |
Accepted |
| 2031 |
A. MANI |
ANTIBACTERIAL ACTIVITY OF HONEY AGAINST SALMONELLA ISOLATES |
Accepted |
| 2032 |
Syed Asadulla |
HONEY BASED POLYHERBAL ANTI TUSSIVE AND EXPECTORANT AND THEIR ANTI-BACTERIAL ANALYSIS |
Accepted |
| 2033 |
Sumit |
SCREENING AND CHARACTERIZATION OF KETOCONAZOLE CO-CRYSTAL USING SOLVENT ASSISTED GRINDING APPROACH FOR SOLUBILITY ENHANCEMENT |
Accepted |
| 2034 |
Ashrita |
KARMA'S RELATED TO SHUKRAVAHA SROTAS AND IT'S APPLIED ASPECTS |
Accepted |
| 2035 |
Ramya |
MANAGEMENT OF KARNANADA WITH SARJIKAKSHARA TAILA KARNAPOORANA AND DASHAMOOLA GHRITA AS RASAYANA-A SINGLE CASE STUDY |
Accepted |
| 2036 |
VEDANTHAM |
CLINICAL STUDY ON EPIDEMIOLOGY OF RESPIRATORY PROBLEMS IN ASSOCIATION WITH VARIOUS RISK FACTORS AT ST. JOSPH GENERAL HOSPITAL |
Under Review |
| 2037 |
C. C. Kaba Mariama |
DETERMINATION OF THE ANTIOXIDANT AND ANTIPLASMODIAL ACTIVITIES OF MITRAGYNA INERMIS AND SPERMACOCE VERTICILLATA |
Accepted |
| 2038 |
Narinder |
FTIR CHARACTERZIATION OF PAMAM DENDRIMERS |
Accepted |
| 2039 |
SREEKANTH |
ESTROGEN SUPPLEMENTS IN
INDIAN CULINARY
|
Accepted |
| 2040 |
Amani A. Sebahi |
AFFILIATION OF “INITIAL CT” FINDINGS WITH MORTALITY IN OLDER PATIENTS COVID-19
|
Under Review |
| 2041 |
NAZEEM |
ORTHOGRAPHIC AND PHONETIC SIMILARITIES AMONG MARKETED PRODUCTS IN COMMUNITY PHARMACIES OVER KERALA |
Accepted |
| 2042 |
G.Ramakrishna |
COMPARATIVE STUDIES FOR FILING AND MARKETING AUTHORIZATION OF GENERICS IN EUROPE, UNITED STATES & INDIA |
Accepted |
| 2043 |
Y. Ratna Sindhu |
DMF PREPARATIONS, REQUIREMENTS FOR MARKETING AUTHORIZATION AND PROCESS OF API IN EUROPEAN UNION |
Accepted |
| 2044 |
V. Triveni |
REGULATORY GUIDELINES FOR GENERIC PRODUCTS REGISTRATION IN MIDDLE EAST COUNTRIES |
Accepted |
| 2045 |
Mayuri |
Coronary Artery Bypass Surgery
|
Accepted |
| 2046 |
Dhanyashree |
COMPARATIVE PHARMACEUTICAL STUDY OF BILWADI AVALEHA ACCORDING TO 2 DIFFERENT METHODS |
Accepted |
| 2047 |
ANJALI |
AN REVIEW ON HRIDROGA AND ITS EFFECTIVE MANAGEMENT THROUGH HARITAKI(TERMINALIA CHEBULA) |
Accepted |
| 2048 |
ANJALI |
AN REVIEW ON HRIDROGA AND ITS EFFECTIVE MANAGEMENT THROUGH HARITAKI(TERMINALIA CHEBULA) |
Under Review |
| 2049 |
Ruaa N. AL-Saraj |
SERUM ALKALINE PHOSPHATASE LEVEL IN NEWLY DIAGNOSED TYPE 2 DIABETES |
Under Review |
| 2050 |
pushpa |
COVID -19: REVIEW ON AVAILABLE DRUGS AND THERAPIES AGAINST SARSCOV-2 |
Accepted |
|
|
